Pediatric Obesity Management Market
Number of pages: 100 | Report Format: PDF | Published date: May 05, 2023
Historical Years – 2021 | Base Year – 2022 | Forecasted Years – 2023-2031
|
Report Attribute |
Details |
|
Market Size Value in 2022 |
US$ 3.02 billion |
|
Revenue Forecast in 2031 |
US$ 4.37 billion |
|
CAGR |
4.2% |
|
Base Year for Estimation |
2022 |
|
Forecast Period |
2023 to 2031 |
|
Historical Year |
2021 |
|
Segments Covered |
Type, Gender, and Region |
|
Regional Scope |
North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
According to the deep-dive market assessment study by Growth Plus Reports, the global pediatric obesity management market was valued at US$ 3.02 billion in 2022 and is expected to register a revenue CAGR of 4.2% to reach US$ 4.37 billion by 2031.
Pediatric Obesity Management Market Fundamentals
Pediatric obesity management therapeutics refers to medications or supplements used to treat obesity in children and adolescents. These treatments are frequently used in conjunction with behavioral therapy and lifestyle changes to assist kids and teenagers in achieving and maintaining a healthy weight. Orlistat, liraglutide, phentermine, topiramate, and other drugs are frequently used to treat childhood obesity. Moreover, pediatric obesity management entails addressing and treating childhood and teenage obesity with a combination of behavioral therapy, lifestyle changes, and, occasionally, medication. Recent developments and trends in this field have emphasized the significance of a thorough, individualized approach to treatment that addresses not only weight loss but also the root causes of obesity, such as unhealthy eating patterns, a lack of physical activity, psychological factors, and social factors. With the creation of smartphone apps, wearable technologies, and other digital tools to assist kids and families in measuring progress, creating goals, and getting support, there has also been a rising emphasis on the role of technology in pediatric obesity management. Research is currently looking into new methods for managing childhood obesity, such as the use of gene therapy, gut microbiome interventions, and other cutting-edge therapies.
This report is a crucial tool for the industry stakeholders to gather all the information about the market, customers, and competition. The report also provides the readers with valuable insights on the segmentation, regions, market size & forecast, revenue CAGRs, and other valuable data to help make informed strategic decisions. The study compiles information gathered from industry participants and specialists across the industry value chain. The report also taps into the qualitative and quantitative assessments by industry analysts. Our reports use different methods for estimating the market size and forecast, including secondary research, surveys and interviews, and statistical modeling. With these steps, our reports provide the most accurate market data. These datasets will cumulatively provide in-depth pediatric obesity management market forecast to the industry stakeholders.
[10]
Pediatric Obesity Management Market Dynamics
The rise in childhood obesity rates worldwide and related health hazards, including type 2 diabetes, cardiovascular disease, and liver disease, are primarily driving the pediatric obesity management market growth. Parents and healthcare professionals are also becoming more aware of the importance of early intervention and efficient treatment options for pediatric obesity, improving the pediatric obesity management market dynamics in terms of revenue. Moreover, there is a growing need for novel, all-encompassing strategies to manage juvenile obesity that address its underlying causes and provide tailored evidence-based treatments. Also, continuous investigations into the biology of obesity and the identification of new therapeutic targets and treatment alternatives are shaping the pediatric obesity management market outlook.
However, the lack of information and instruction regarding childhood obesity among parents and healthcare professionals is considered a significant pediatric obesity management market restraining factor. This can delay receiving the proper care and make it challenging to execute successful behavioral and lifestyle treatments. The high cost of treating obesity, which includes prescription drugs, nutritional supplements, and other interventions, is another barrier to care for some families. Furthermore, there is a lack of agreement among healthcare professionals regarding the best ways to treat pediatric obesity, which can make it challenging to develop evidence-based recommendations and protocols. Regulatory and reimbursement issues can also impact the creation and accessibility of novel treatments for pediatric obesity.
Pediatric Obesity Management Market Ecosystem
Pediatric Obesity Management Market, by Type
Pediatric Obesity Management Market, by Distribution Channel
Pediatric obesity management Market by Type
[333]
Based on the types, the pediatric obesity management market is segmented into medication and supplements. The medication segment is further sub-segmented into lipase inhibitors, anorectics, serotonin receptor agonists, incretin mimetics, and melanocortin 4 (MC4) receptor agonists.
Medication accounted for the largest revenue share of the global market in terms of pediatric obesity management market forecast. When behavioral changes and lifestyle therapies alone are ineffective, medications significantly treat pediatric obesity. The FDA has approved the use of several drugs, including orlistat (Lipase inhibitor), liraglutide (incretin mimetics), and phentermine/topiramate (Anorectics), in obese adolescents. Among other ways, these drugs reduce dietary fat absorption, reduce hunger, and change glucose metabolism. These drugs can help the patient lose weight and improve their metabolic health, but they should only be used under the supervision of a doctor because they may have negative side effects or interact with other drugs. Medication should always be used in conjunction with lifestyle changes, including diet and exercise, to have the best benefits. Research is still being done on new pharmaceutical targets for treating childhood obesity and customized therapy based on each patient's unique genetic and metabolic profile.
Segmentation of the market refers to the division of the industry into subgroups based on factors such as type, distribution channel, and region. Market segmentation data helps businesses to understand the preferences and unique needs of different customer groups and develop targeted sales strategies. This information also helps in identifying potential pediatric obesity management market growth opportunities.
Pediatric obesity management Market by Region
Based on the regions, the global pediatric obesity management market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
According to the analysis of the pediatric obesity management market overview, North America accounted for the largest global market revenue share. The prevalence of childhood obesity is significant in the area, with the United States alone accounting for 20% of instances worldwide. Due to this, there is a need for efficient methods to manage obesity, which has prompted the creation and widespread use of numerous treatment approaches. The healthcare system in North America is very sophisticated, with significant government funding for healthcare projects and investments in research and development. The availability of cutting-edge technologies and effective pediatric obesity management treatments is the outcome of this. The area's robust economy also allows people and medical facilities to cover the significant expenditures of managing pediatric obesity.
Based on the regions, the global pediatric obesity management market is segmented into:
Regional demarcation of the industry will provide information on geographic pockets regarding pediatric obesity management market outlook, size, share, and growth rate. This data helps businesses evaluate the expansion potential into new regional markets, understand the competitive threats across different regions, and develop localized sales and expansion strategies.
Key Components of the Report
Pediatric obesity management Market Competitive Landscape
Multiple companies across the globe are investing in raising awareness and new product launches, which is expected to improve the pediatric obesity management market outlook. Notable market participants account for the largest portion of the global pediatric obesity management market size include
The market competitive landscape is performed by collecting and analyzing information about the key competitors, the present industry trends, and market dynamics. It includes information collection and analysis on factors such as products, pricing, geographic outreach, customer demographics, marketing strategies, and recent developments. Competitive landscape assessment will help businesses identify the current prevalent or potential opportunities and threats, keeping in mind the pediatric obesity management industry trends.
Pediatric obesity management Market Strategic Development
Key Strengths of Our Report
Target Audience to Benefit from this Report.
Reasons to Buy this Report
Pediatric obesity management refers to contraceptive methods that do not use hormones to prevent pregnancy.
The total global pediatric obesity management market size in 2022 was US$ 3.02 billion.
North America will have the largest pediatric obesity management market size during the forecast period from 2023 to 2031.
The global pediatric obesity management market is expected to grow with a revenue CAGR of 4.2% during the forecast period from 2023 to 2031.
The resultant market size of the pediatric obesity management market in 2031 will be US$ 4.37 billion.
Lack of knowledge among the population and side effects related to the medications are the major challenge hampering the growth of the global pediatric obesity management market.
The major strategies key market players adopt involve strategic partnerships and collaborations to expand their market reach and capabilities.
The increased need for obesity control strategies without any adverse effects is the major driving factor that necessitates the use of pediatric obesity management.
Key players in the pediatric obesity management market are Pfizer Inc., F. Hoffmann-La Roche Ltd, GlaxoSmithKline plc., AstraZeneca, Herbalife Ltd., Apollo Endosurgery, and Ethicon, Inc.
*Insights on financial performance are subject to the availability of information in the public domain